https://www.intralytix.com/ monthly 0.9 https://www.intralytix.com/home monthly 0.9 https://www.intralytix.com/news monthly 0.9 https://www.intralytix.com/faq monthly 0.9 https://www.intralytix.com/product monthly 0.9 https://www.intralytix.com/products monthly 0.9 https://www.intralytix.com/patents monthly 0.9 https://www.intralytix.com/publications monthly 0.9 https://www.intralytix.com/publication monthly 0.9 https://www.intralytix.com/conferences monthly 0.9 https://www.intralytix.com/jobs monthly 0.9 https://www.intralytix.com/contact monthly 0.9 https://www.intralytix.com/board-of-directors monthly 0.9 https://www.intralytix.com/senior-managment monthly 0.9 https://www.intralytix.com/corporate monthly 0.9 https://www.intralytix.com/governance monthly 0.9 https://www.intralytix.com/sponsorship monthly 0.9 https://www.intralytix.com/technology monthly 0.9 https://www.intralytix.com/food-safety monthly 0.9 https://www.intralytix.com/environmental-sanitation monthly 0.9 https://www.intralytix.com/veterinary-applications monthly 0.9 https://www.intralytix.com/human-therapeutics monthly 0.9 https://www.intralytix.com/probiotics monthly 0.9 https://www.intralytix.com/clinical-trials monthly 0.9 https://www.intralytix.com/phage-history monthly 0.9 https://www.intralytix.com/access-pending monthly 0.9 https://www.intralytix.com/clinicaltrials/ShigActive monthly 0.9 https://www.intralytix.com/clinicaltrials/VRELysin monthly 0.9 https://www.intralytix.com/clinicaltrials/EcoActive monthly 0.9 https://www.intralytix.com/clinicaltrials/EcoActive-JHU monthly 0.9 https://www.intralytix.com/product/1?e=ListShield monthly 0.9 https://www.intralytix.com/product/3?e=SalmoFresh monthly 0.9 https://www.intralytix.com/product/7?e=SalmoLyse monthly 0.9 https://www.intralytix.com/product/8?e=ShigaShield monthly 0.9 https://www.intralytix.com/product/9?e=ListPhage monthly 0.9 https://www.intralytix.com/product/10?e=Ecolicide monthly 0.9 https://www.intralytix.com/product/11?e=EcoShield monthly 0.9 https://www.intralytix.com/product/12?e=CampyShield monthly 0.9 https://www.intralytix.com/product/16?e=FortiPhage monthly 0.9 https://www.intralytix.com/product/21?e=SuperBiotix%E2%84%A2-UTS monthly 0.9 https://www.intralytix.com/product/22?e=PhageBiotix%E2%84%A2-GI monthly 0.9 https://www.intralytix.com/product/23?e=FortiPhage%E2%84%A2-Plus monthly 0.9 https://www.intralytix.com/article/1?e=World-Congress-on-Beneficial-Microbes%3A-Food-Pharma-Aqua-%26-Beverages-Industry monthly 0.9 https://www.intralytix.com/article/2?e=Seafood-Expo-North-America%2FSeafood-Processing-North-America-%28SENA%29 monthly 0.9 https://www.intralytix.com/article/3?e=Baltimore-Business-Journal monthly 0.9 https://www.intralytix.com/article/4?e=Health-Canada monthly 0.9 https://www.intralytix.com/article/5?e= monthly 0.9 https://www.intralytix.com/article/6?e= monthly 0.9 https://www.intralytix.com/article/7?e= monthly 0.9 https://www.intralytix.com/article/8?e= monthly 0.9 https://www.intralytix.com/article/9?e= monthly 0.9 https://www.intralytix.com/article/10?e= monthly 0.9 https://www.intralytix.com/article/11?e= monthly 0.9 https://www.intralytix.com/article/12?e= monthly 0.9 https://www.intralytix.com/article/13?e= monthly 0.9 https://www.intralytix.com/article/14?e= monthly 0.9 https://www.intralytix.com/article/15?e= monthly 0.9 https://www.intralytix.com/article/16?e= monthly 0.9 https://www.intralytix.com/article/18?e= monthly 0.9 https://www.intralytix.com/article/19?e= monthly 0.9 https://www.intralytix.com/article/20?e= monthly 0.9 https://www.intralytix.com/article/21?e= monthly 0.9 https://www.intralytix.com/article/22?e=Intralytix-Wins-Army-Grant-To-Develop-A-Phage-Based-Probiotic-To-%0D%0A%09%09%09%09Manage-Shigella-Infections monthly 0.9 https://www.intralytix.com/article/23?e=Intralytix-Receives-USDA-NIFA-Phase-II-SBIR-Grant-To-Develop-A-Phage-Based-Application-To-Protect-Hatchery-Raised-Oyste monthly 0.9 https://www.intralytix.com/article/24?e=Intralytix-Wins-Army-Grant-for-Salmonella-and-Shigella-Technology monthly 0.9 https://www.intralytix.com/article/25?e=Intralytix-awarded-patent-by-USPTO-for-Bacteriophage-treatment-%0D%0A----------------of-colonization-by-pathogen-bacteria-i monthly 0.9 https://www.intralytix.com/article/26?e=Intralytix-wins-Phase-III-Army-grant-for-E.-Coli-technology monthly 0.9 https://www.intralytix.com/article/27?e=Interview-with-Intralytix%27s-Dr.-Alexander-Sulakvelidze monthly 0.9 https://www.intralytix.com/article/30?e= monthly 0.9 https://www.intralytix.com/article/31?e= monthly 0.9 https://www.intralytix.com/article/32?e=Intralytix-Wins-Popular-Science-%22Best-of-What%27s-New%22-Award%0D%0A----------------for-its-food-safety-product-ListShield%26trade monthly 0.9 https://www.intralytix.com/article/33?e= monthly 0.9 https://www.intralytix.com/article/34?e= monthly 0.9 https://www.intralytix.com/article/35?e=U.S.-OKs-spray-to-kill-food-bacteria%0D%0ABaltimore-firm-wins-FDA-nod-for-mix-of-beneficial-viruses monthly 0.9 https://www.intralytix.com/article/36?e=FDA-approves-Intralytix%27s-Food-Safety-Product-%28LMP-102%29 monthly 0.9 https://www.intralytix.com/article/37?e= monthly 0.9 https://www.intralytix.com/article/38?e= monthly 0.9 https://www.intralytix.com/article/39?e=Voice-of-America monthly 0.9 https://www.intralytix.com/article/40?e=Intralytix-Acquires-Site-for-New-Headquarters monthly 0.9 https://www.intralytix.com/article/41?e=Wired-Magazine monthly 0.9 https://www.intralytix.com/article/42?e= monthly 0.9 https://www.intralytix.com/article/43?e= monthly 0.9 https://www.intralytix.com/article/44?e=Intralytix-Receives-FDA-clearance-to-initiate-Phase-I-%2F-IIa-clinical-trials monthly 0.9 https://www.intralytix.com/article/45?e= monthly 0.9 https://www.intralytix.com/article/47?e= monthly 0.9 https://www.intralytix.com/article/48?e= monthly 0.9 https://www.intralytix.com/article/49?e= monthly 0.9 https://www.intralytix.com/article/50?e=FoodTech-Source monthly 0.9 https://www.intralytix.com/article/51?e=Agricultural-Research-%0D%0A------Magazine monthly 0.9 https://www.intralytix.com/article/52?e=Smithsonian-Magazine monthly 0.9 https://www.intralytix.com/article/55?e=McMahonMed monthly 0.9 https://www.intralytix.com/article/56?e=Science-Service-Inc. monthly 0.9 https://www.intralytix.com/article/57?e=Washington-Techway monthly 0.9 https://www.intralytix.com/article/58?e=New-York-Times monthly 0.9 https://www.intralytix.com/article/59?e=DoubleTwist monthly 0.9 https://www.intralytix.com/article/60?e=Intralytix-and-Ferring-Pharmaceuticals-Collaborate-In-Novel-Bacteriophage-Based-IBD-Drug-Development-Project monthly 0.9 https://www.intralytix.com/article/61?e=Intralytix-Receives-Additional-Regulatory-Clearance-for-SalmoFresh-tm monthly 0.9 https://www.intralytix.com/article/62?e=Intralytix-Receives-Additional-Regulatory-Approval-For-ListShield-tm---Phage-Based-Food-Safety-Product-Effective-Aga monthly 0.9 https://www.intralytix.com/article/64?e=Intralytix-Wins-USDA-Grant-To-Develop-A-Phage-Based-Application-To-Protect-Hatchery-Raised-Oysters-From-The-Bacterial-Pa monthly 0.9 https://www.intralytix.com/article/65?e=Intralytix-Wins-Regulatory-Approval-For-Phage-Based-Food-Safety-Product-Effective-Against-Salmonella monthly 0.9 https://www.intralytix.com/article/66?e=Intralytix-Signs-Multiple-Project-Collaboration-Agreement-with-Procter-%26-Gamble monthly 0.9 https://www.intralytix.com/article/67?e=Intralytix-Awarded-Grant-For-Managing-Salmonella-in-Food monthly 0.9 https://www.intralytix.com/article/68?e=Intralytix-Completes-Regulatory-Clearance-for-Phage-Based-E.-coli-Food-Safety-Technology monthly 0.9 https://www.intralytix.com/article/69?e=Intralytix-Receives-Follow-On-Army-Contract-To-Develop-A-Phage-Based-Probiotic-To-Manage-Shigella-Infections monthly 0.9 https://www.intralytix.com/article/70?e=Intralytix%27s-CSO-Appointed-Editor-In-Chief-of-New-Phage-Journal monthly 0.9 https://www.intralytix.com/article/71?e=Intralytix-Receives-FDA-Regulatory-Clearance-for-Phage-Based-E.-coli-Technology monthly 0.9 https://www.intralytix.com/article/72?e=Intralytix-Wins-Army-Grant-To-Develop-A-Phage-Based-Probiotic-To-Manage-Shigella-Infections monthly 0.9 https://www.intralytix.com/article/73?e=Intralytix-Receives-a-Phase-I-U.S.-Army-grant-supporting-the-development-of-a-phage-based-product-for-treating-wounds-in monthly 0.9 https://www.intralytix.com/article/74?e=Intralytix-Wins-Army-Grant-to-develop-a-bacteriophage-based-food-safety-product-for-reducing-or-eliminating-contaminatio monthly 0.9 https://www.intralytix.com/article/76?e= monthly 0.9 https://www.intralytix.com/article/77?e= monthly 0.9 https://www.intralytix.com/article/78?e=Intralytix-Inc.-and-Ferring-Pharmaceuticals-partner-to-develop-bacteriophage-treatments monthly 0.9 https://www.intralytix.com/article/79?e=Intralytix-Receives-FDA-Regulatory-Clearance-for-Phage-Based-Shigella-Technology monthly 0.9 https://www.intralytix.com/article/80?e=Intralytix-phage-based-Shigella-tech-backed-by-FDA monthly 0.9 https://www.intralytix.com/article/81?e=Intralytix-was-recently-given-a-positive-%23LuxTake-by-Lux-Research monthly 0.9 https://www.intralytix.com/article/82?e=Lesaffre-invests-in-Intralytix-a-US-biotechnology-company monthly 0.9 https://www.intralytix.com/article/83?e=Intralytix-Inc.-enters-into-a-collaboration-agreement-with-the-G.-N.-Gabrichevsky-Research-Institute-for-Epidemiology-a monthly 0.9 https://www.intralytix.com/article/84?e=Intralytix-Inc.-receives-a-U.S.-Army-award-in-support-of-studies-on-bacteriophages-and-the-food-microbiome. monthly 0.9 https://www.intralytix.com/article/85?e=Contest-For-The-Best-Cartoon-Characters-Of-Bacteriophages monthly 0.9 https://www.intralytix.com/article/86?e=UPDATE%3A-EcoActive-tm-Bacteriophage-Therapy-Enters-Clinical-Trial-at-the-Mount-Sinai-Hospital monthly 0.9 https://www.intralytix.com/article/87?e=Intralytix-Enters-Into-Joint-Collaboration-Agreement-with-the-Eliava-Foundation-and-Ferring-Pharmaceuticals monthly 0.9 https://www.intralytix.com/article/88?e=Intralytix-Receives-FDA-Regulatory-Clearance-and-Expanded-Use-Including-in-Ground-Beef-for-Phage-Based-E.-coli-Food-Sa monthly 0.9 https://www.intralytix.com/article/89?e=Intralytix-Receives-FDA-Regulatory-Clearance-for-Expanded-Use-in-Red-Meat-for-Phage-Based-Salmonella-Technology monthly 0.9 https://www.intralytix.com/article/90?e=Intralytix-Receives-Multimillion-Dollar-Clinical-Trial-Award-From-NIAID-to-Manage-Shigella-Infections-in-Humans monthly 0.9 https://www.intralytix.com/article/91?e=Intralytix-enters-into-CRADA-with-the-U.S.-Army-Combat-Capabilities-Development-Command-Soldier-Center monthly 0.9 https://www.intralytix.com/article/92?e=Leading-Bacteriophage-Company-Expands-Clinical-Pipeline-Poised-for-Growth-in-Maryland monthly 0.9 https://www.intralytix.com/article/93?e=Intralytix-awarded-patent-by-USPTO-for-novel-Shigella-bacteriophages-and-their-uses monthly 0.9 https://www.intralytix.com/article/94?e=How-bacteriophages-can-help-us-shape-the-microbiome monthly 0.9 https://www.intralytix.com/article/95?e=Intralytix-Receives-SBIR-Grant-to-Develop-Phage-Preparation-for-Reducing-Vibrio-parahaemolyticus-Contamination-of-Foods monthly 0.9 https://www.intralytix.com/article/97?e=Phage-Against-the-Machine monthly 0.9 https://www.intralytix.com/article/98?e=Intralytix-receives-a-positive-%23LuxTake-by-Lux-Research monthly 0.9 https://www.intralytix.com/article/99?e=Antibiotic-resistant-%27superbugs%27-could-be-the-next-big-health-threat.-Beneficial-viruses-could-be-the-solution monthly 0.9 https://www.intralytix.com/article/100?e=Intralytix-receives-Fast-Track-NIH-SBIR-contract-to-develop-a-universal-scale-independent-AI-based-platform-for-manufac monthly 0.9 https://www.intralytix.com/article/101?e=Intralytix%3A-Illuminating-the-Path-to-Safer-Food-Processing monthly 0.9 https://www.intralytix.com/article/102?e=Intralytix-Receives-FDA-Regulatory-Clearance-for-Phage-Based-Campylobacter-Technology monthly 0.9 https://www.intralytix.com/article/103?e=Intralytix-Receives-FDA-Clearance-for-Investigational-New-Drug-Application-for-Phase-1%2F2a-Clinical-Trials-for-Shigella-t monthly 0.9 https://www.intralytix.com/article/104?e=Food-Poisoning-Sickens-Millions-a-Year.-Now-a-Surprising-Weapon-Is-Helping-Protect-Against-Contamination monthly 0.9 https://www.intralytix.com/article/105?e=AB-Agri-has-partnered-with-US-biotechnology-company-Intralytix-to-explore-the-use-of-bacteriophages-%E2%80%93-the-natural-viru monthly 0.9 https://www.intralytix.com/article/106?e=How-bacteria-killing-viruses-are-being-used-to-keep-food-safe monthly 0.9 https://www.intralytix.com/article/107?e=The-State-of-Phage-Therapy monthly 0.9 https://www.intralytix.com/article/108?e=Intralytix-Granted-Clearance-by-the-FDA-for-an-Investigational-New-Drug-Application-for-Phase-1%2F2a-Clinical-Trials-for-V monthly 0.9 https://www.intralytix.com/article/109?e=Intralytix-receives-Phase-II-Fast-Track-NIH-SBIR-contract-to-continue-development-of-a-universal-scale-independent-AI-b monthly 0.9 https://www.intralytix.com/article/110?e=H.C.-Wainwright-%26-Co.-LLC-hosts-the-First-Annual-Bacteriophage-Conference monthly 0.9 https://www.intralytix.com/article/111?e=Intralytix-Receives-USDA-NIFA-Phase-III-SBIR-Grant-To-Optimize-Application-of-Its-Salmonella-Targeting-Bacteriophage-Pr monthly 0.9 https://www.intralytix.com/article/112?e=Intralytix-Launches-Phase-1%2F2a-Phage-Therapy-Trial-to-Prevent-Illness-Caused-by-Shigella monthly 0.9 https://www.intralytix.com/article/113?e=Full-Enrollment-of-Phase-1-Safety-Trial-Achieved-of-Intralytix-Phage-Product-to-Prevent-Illness-Caused-by-Shigella monthly 0.9 https://www.intralytix.com/article/114?e=Intralytix%27s-EcoActive-Phase-1%2F2a-Phage-Trial-Begins-Enrollment-at-Johns-Hopkins-University-in-the-Baltimore-Maryland-M monthly 0.9 https://www.intralytix.com/article/115?e=Intralytix-Launches-Phase-1%2F2a-Phage-Therapy-Trial-of-Its-VRELysin-tm-Phage-Preparation-to-Assess-Safety-and-Effica monthly 0.9 https://www.intralytix.com/article/116?e=Intralytix-Awarded-Patent-by-the-European-Patent-Office-for-Novel-Shigella-Bacteriophages-and-their-Uses monthly 0.9 https://www.intralytix.com/article/117?e=Intralytix-Receives-FDA-Regulatory-Clearance-for-Expanded-Use-in-Grain-and-Grain-Products-for-Phage-Based-Salmonella-Tec monthly 0.9 https://www.intralytix.com/article/118?e=Intralytix-Receives-FDA-Regulatory-Clearance-for-Expanded-Use-in-Grain-and-Grain-Products-for-Phage-Based-E.-coli-Techno monthly 0.9 https://www.intralytix.com/article/119?e=Intralytix-receives-Safe-Quality-Food-%28SQF%29-certification%0D%0A monthly 0.9 https://www.intralytix.com/article/120?e=Intralytix%3A-Leveraging-Phage-Power-for-Food-Safety monthly 0.9 https://www.intralytix.com/article/121?e=Intralytix%3A-Food-Safety-in-the-21st-Century%3A-Bacteriophage-based-Biocontrol-as-an-Emerging-Green-Technology-for-Improvin monthly 0.9 https://www.intralytix.com/article/122?e=Intralytix%3A-Revolutionizing-Healthcare-and-Food-Safety-with-Cutting-Edge-Bacteriophage-Technology monthly 0.9 https://www.intralytix.com/article/123?e=Intralytix-Receives-FDA-CVM-Approval-for-Salmonella-Targeting-Phage-Preparation-for-Use-in-Pet-Food-Applications monthly 0.9 https://www.intralytix.com/article/124?e=Intralytix-and-Life-Extension-Collaborate-to-Advance-Bacteriophage-Based-Interventions-in-the-VMS-Space monthly 0.9 https://www.intralytix.com/job/23?e=Manufacturing-Technician monthly 0.9 https://www.intralytix.com/principal/2?e=Alexander-Sulakvelidze monthly 0.9 https://www.intralytix.com/principal/4?e=Patrick-Hervy monthly 0.9 https://www.intralytix.com/principal/7?e=Jon-Kully monthly 0.9 https://www.intralytix.com/principal/8?e=Brice-Audren-Rich%C3%A9 monthly 0.9 https://www.intralytix.com/principal/9?e=Scott-Gibbons-Jr. monthly 0.9 https://www.intralytix.com/principal/10?e=Jennifer-Schwartz monthly 0.9 https://www.intralytix.com/principal/11?e=Greg-Strang monthly 0.9 https://www.intralytix.com/principal/12?e=Hal-Warso monthly 0.9 https://www.intralytix.com/principal/13?e=Bradley-Anderson monthly 0.9 https://www.intralytix.com/principal/14?e=Joelle-Woolston monthly 0.9 https://www.intralytix.com/principal/15?e=Mel-Ruzicka monthly 0.9 https://www.intralytix.com/principal/16?e=Alexander-Sulakvelidze monthly 0.9 https://www.intralytix.com/publication/1?e=Additive-Approach-for-Inactivation-of-Escherichia-coli-O157%3AH7-Salmonella-and-Shigella-spp.-on-Contaminated-Fresh-Frui monthly 0.9 https://www.intralytix.com/publication/2?e=Bacteriophage-Cocktail-for-Biocontrol-of-Salmonella-in-Dried-Pet-Food. monthly 0.9 https://www.intralytix.com/publication/3?e=Efficacy-of-Lytic-Bacteriophage-Preparation-in-Reducing-Salmonella-In-Vitro-on-Turkey-Breast-Cutlets-and-on-Ground-Tur monthly 0.9 https://www.intralytix.com/publication/4?e=Reduction-of-Salmonella-on-chicken-meat-and-chicken-skin-by-combined-or-sequential-application-of-lytic-bacteriophage-wi monthly 0.9 https://www.intralytix.com/publication/5?e=Bacteriophages-safely-reduce-Salmonella-contamination-in-pet-food-and-raw-pet-food-ingredients. monthly 0.9 https://www.intralytix.com/publication/6?e=Reduction-of-Salmonella-on-chicken-breast-fillets-stored-under-aerobic-or-modified-atmosphere-packaging-by-the-applicati monthly 0.9 https://www.intralytix.com/publication/7?e=Survival-of-Salmonella-Newport-on-Whole-and-Fresh-Cut-Cucumbers-Treated-with-Lytic-Bacteriophages. monthly 0.9 https://www.intralytix.com/publication/8?e=Effects-of-Salmonella-bacteriophage-nisin-and-potassium-sorbate-and-their-combination-on-safety-and-shelf-life-of-fresh monthly 0.9 https://www.intralytix.com/publication/9?e=SalmoFresh-tm-effectiveness-in-controlling-Salmonella-on-romaine-lettuce-mung-bean-sprouts-and-seeds. monthly 0.9 https://www.intralytix.com/publication/10?e=A-Bacteriophage-Cocktail-Eliminates-Salmonella-Typhimurium-from-the-Human-Colonic-Microbiome-while-Preserving-Cytokine-S monthly 0.9 https://www.intralytix.com/publication/11?e=Treatment-of-fresh-produce-with-a-Salmonella-targeted-bacteriophage-cocktail-is-compatible-with-chlorine-or-peracetic-ac monthly 0.9 https://www.intralytix.com/publication/12?e=Bacteriophages-reduce-experimental-contamination-of-hard-surfaces-tomato-spinach-broccoli-and-ground-beef-by-Escheri monthly 0.9 https://www.intralytix.com/publication/13?e=Effectiveness-of-bacteriophages-in-reducing-Escherichia-coli-O157%3AH7-on-fresh-cut-cantaloupes-and-lettuce. monthly 0.9 https://www.intralytix.com/publication/14?e=Bacteriophage-cocktail-significantly-reduces-Escherichia-coli-O157%3AH7-contamination-of-lettuce-and-beef-but-does-not-pr monthly 0.9 https://www.intralytix.com/publication/15?e=Biocontrol-of-Escherichia-coli-O157%3AH7-on-fresh-cut-leafy-greens. monthly 0.9 https://www.intralytix.com/publication/16?e=Lytic-bacteriophages-reduce-Escherichia-coli-O157%3AH7-on-fresh-cut-lettuce-introduced-through-cross-contamination. monthly 0.9 https://www.intralytix.com/publication/17?e=Phage-biocontrol-improves-food-safety-by-significantly-reducing-both-the-concentration-and-occurrence-of-Escherichia-col monthly 0.9 https://www.intralytix.com/publication/18?e=Biocontrol-of-Listeria-monocytogenes-on-Fresh-Cut-Produce-by-Treatment-with-Lytic-Bacteriophages-and-a-Bacteriocin. monthly 0.9 https://www.intralytix.com/publication/19?e=Optimizing-Concentration-and-Timing-of-a-Phage-Spray-Application-To-Reduce-Listeria-monocytogenes-on-Honeydew-Melon-Tiss monthly 0.9 https://www.intralytix.com/publication/20?e=Bacteriophage-cocktail-significantly-reduces-or-eliminates-Listeria-monocytogenes-contamination-on-lettuce-apples-chee monthly 0.9 https://www.intralytix.com/publication/21?e=Reduction-of-Listeria-monocytogenes-on-chicken-breasts-by-combined-treatment-with-UV-C-light-and-bacteriophage-ListShiel monthly 0.9 https://www.intralytix.com/publication/22?e=Applicability-of-commercial-phage-based-products-against-Listeria-monocytogenes-for-improvement-of-food-safety-in-Spanis monthly 0.9 https://www.intralytix.com/publication/23?e=Bacteriophage-Administration-Reduces-the-Concentration-of-Listeria-monocytogenes-in-the-Gastrointestinal-Tract-and-Its-T monthly 0.9 https://www.intralytix.com/publication/24?e=Bacteriophage-preparation-lytic-for-Shigella-significantly-reduces-Shigella-sonnei-contamination-in-various-foods. monthly 0.9 https://www.intralytix.com/publication/25?e=Bacteriophage-administration-significantly-reduces-Shigella-colonization-and-shedding-by-Shigella-challenged-mice-withou monthly 0.9 https://www.intralytix.com/publication/26?e=Employing-list-shield-bacteriophage-as-a-bio-control-intervention-for-Listeria-monocytogenes-from-raw-beef-surface-and-m monthly 0.9 https://www.intralytix.com/publication/27?e=Effectiveness-of-a-phage-cocktail-as-a-biocontrol-agent-against-L.-monocytogenes-biofilms. monthly 0.9 https://www.intralytix.com/publication/28?e=A-Bacteriophage-Cocktail-Significantly-Reduces-Listeria-monocytogenes-without-Deleterious-Impact-on-the-Commensal-Gut-Mi monthly 0.9 https://www.intralytix.com/publication/29?e=Evaluation-of-a-Preharvest-Bacteriophage-Therapy-for-Control-of-Salmonella-within-Bovine-Peripheral-Lymph-Nodes monthly 0.9 https://www.intralytix.com/publication/30?e=Bacteriophages-against-Vibrio-coralliilyticus-and-Vibrio-tubiashii%3A-Isolation-Characterization-and-Remediation-of-Larv monthly 0.9 https://www.intralytix.com/publication/31?e=Phage-Biocontrol-Applications-in-Food-Production-and-Processing monthly 0.9 https://www.intralytix.com/publication/32?e=A-Bacteriophage-Cocktail-Targeting-Yersinia-pestis-Provides-Strong-Post-Exposure-Protection-in-a-Rat-Pneumonic-Plague-Mo monthly 0.9 https://www.intralytix.com/publication/33?e=Safety-and-Tolerability-of-ShigActive-tm-a-Shigella-spp.-Targeting-Bacteriophage-Preparation-in-a-Phase-1-Randomiz monthly 0.9 https://www.intralytix.com/publication/34?e=Biocontrol-of-Two-Escherichia-coli-O157%3AH7-Strains-and-a-Nonpathogenic-Surrogate-E.-coli-in-Wheat-Grains-and-Wheat-Milli monthly 0.9 https://www.intralytix.com/publication/35?e=A-bacteriophage-cocktail-targeting-Escherichia-coli-reduces-E.-coli-in-simulated-gut-conditions-while-preserving-a-non- monthly 0.9 https://www.intralytix.com/publication/36?e=Prophylactic-Administration-of-a-Bacteriophage-Cocktail-Is-Safe-and-Effective-in-Reducing-Salmonella-enterica-Serovar-Ty monthly 0.9 https://www.intralytix.com/publication/37?e=Comparison-of-Crohn%E2%80%99s-disease-associated-adherent-invasive%0A------------Escherichia-coli%0A------------%28AIEC%29-from-France monthly 0.9 https://www.intralytix.com/publication/38?e=ECOPHAGE%3A-Combating-Antimicrobial-Resistance-Using-Bacteriophages-for-Eco-Sustainable-Agriculture-and-Food-Systems monthly 0.9 https://www.intralytix.com/publication/39?e=Bacteriophages-improve-survival-and-metamorphosis-of-larval-Pacific-oysters-%28Crassostrea-gigas%29-exposed-to-Vibrio-corall monthly 0.9 https://www.intralytix.com/publication/40?e=Phage-biocontrol-for-reducing-bacterial-foodborne-pathogens-in-produce-and-other-foods monthly 0.9 https://www.intralytix.com/publication/41?e=Bacteriophage-Applications-for-Food-Production-and-Processing monthly 0.9 https://www.intralytix.com/publication/42?e=Effect-of-a-bacteriophage-cocktail-in-combination-with-modified-atmosphere-packaging-in-controlling-Listeria-monocytogen monthly 0.9 https://www.intralytix.com/publication/43?e=Salmonella-Phages-and-Prophages%3A-Genomics-Taxonomy-and-Applied-Aspects monthly 0.9 https://www.intralytix.com/publication/44?e=Evaluation-of-consumers%E2%80%99-perception-and-willingness-to-pay-for-bacteriophage-treated-fresh-produce monthly 0.9 https://www.intralytix.com/publication/45?e=Using-lytic-bacteriophages-to-eliminate-or-significantly-reduce-contamination-of-food-by-foodborne-bacterial-pathogens monthly 0.9 https://www.intralytix.com/publication/46?e=A-Yersinia-pestis-specific-lytic-phage-preparation-significantly-reduces-viable-Y.-pestis-on-various-hard-surfaces-expe monthly 0.9 https://www.intralytix.com/publication/47?e=Bacteriophage-Therapy-for-Control-of-Necrotic-Enteritis-of-Broiler-Chickens-Experimentally-Infected-with-Clostridium-per monthly 0.9 https://www.intralytix.com/publication/48?e=Bacteriophage-therapy-of-venous-leg-ulcers-in-humans%3A-results-of-a-phase-I-safety-trial monthly 0.9 https://www.intralytix.com/publication/49?e=Phage-therapy%3A-an-attractive-option-for-dealing-with-antibiotic-resistant-bacterial-infections monthly 0.9 https://www.intralytix.com/publication/50?e=The-use-of-a-novel-biodegradable-preparation-capable-of-the-sustained-release-of-bacteriophages-and-ciprofloxacin-in-th monthly 0.9 https://www.intralytix.com/publication/51?e=A-novel-sustained%E2%80%90release-matrix-based-on-biodegradable-poly%28ester-amide%29s-and-impregnated-with-bacteriophages-and-an- monthly 0.9 https://www.intralytix.com/publication/52?e=Bacteriophage-Therapy monthly 0.9 https://www.intralytix.com/publication/53?e=Bacteriophages-as-therapeutic-agents monthly 0.9 https://www.intralytix.com/publication/54?e=Examination-of-Bacteriophage-as-a-Biocontrol-Method-for-Salmonella-on-Fresh-Cut-Fruit%3A-A-Model-Study monthly 0.9 https://www.intralytix.com/clinical-trial/1?e=EcoActive-tm monthly 0.9 https://www.intralytix.com/clinical-trial/3?e=VRELysin-tm monthly 0.9 https://www.intralytix.com/clinical-trial/4?e=ShigActive-tm monthly 0.9 https://www.intralytix.com/clinical-trial/5?e=EcoActive-tm monthly 0.9